CQDM | SynergiQc program - Quebec Funding Program for Biopharmaceutical Research

Through the SynergiQc program, the Canadian Cancer Society (CCS), the Cole Foundation (and collaborating donors), Oncopole – Pôle cancer du FRQS (Oncopole) and CQDM unite forces to support collaborative translational research and development (R&D) projects on pediatric and young adult cancers, in particular leukemia and lymphoma. This partnership creates a unique funding mechanism to bring together experts from academia and industry to support the development of platforms, tools and biopharmaceutical products that will pave the way for new advances in pediatric cancer prevention, diagnosis and treatment.

This CQDM, CCS, Cole Foundation and Oncopole SynergiQc initiative specifically focuses on pediatric and young adult cancer, in particular leukemia and lymphoma. The intent of the initiative is:

• To increase the number of cooperative endeavours and partnerships between Quebec’s universities and companies in the life sciences industry towards improved outcomes for pediatric and young adult cancer patients;
• To foster technological maturation and the creation of industrial value, leading to economic benefits for both the project’s stakeholders and for Quebec in general;
• To promote the knowledge, capabilities, and the new technologies developed in public institutions and facilitating uptake by industry.

Log in with Google

OR

Get Started to Apply